Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D.

Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D.

عرض إصدارات أخرى (1)

Multiple sclerosis (MS) is a complex trait in which allelic variation in the MHC class II region exerts the single strongest effect on genetic risk. Epidemiological data in MS provide strong evidence that environmental factors act at a population level to influence the unusual geographical distribut...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Ramagopalan, S, Maugeri, N, Handunnetthi, L, Lincoln, MR, Orton, S, Dyment, D, Deluca, G, Herrera, B, Chao, M, Sadovnick, A, Ebers, G, Knight, J
التنسيق:	Journal article
اللغة:	English
منشور في:	2009

مواد مشابهة

Expression of the multiple sclerosis associated MHC class II allele HLA-DRB1*1501 is regulated by vitamin D
حسب: Ebers, G, وآخرون
منشور في: (2008)

Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D.
حسب: Sreeram V Ramagopalan, وآخرون
منشور في: (2009-02-01)

Expression of the multiple sclerosis associated MHC class II allele HLA-DRBI*1501 is regulated by vitamin D
حسب: Ebers, G, وآخرون
منشور في: (2008)

HLA class I alleles tag HLA-DRB1*1501 haplotypes for differential risk in multiple sclerosis susceptibility.
حسب: Chao, M, وآخرون
منشور في: (2008)

Parent-of-origin of HLA-DRB1*1501 and age of onset of multiple sclerosis.
حسب: Ramagopalan, S, وآخرون
منشور في: (2009)

Parental transmission of HLA-DRB1*15 in multiple sclerosis.
حسب: Ramagopalan, S, وآخرون
منشور في: (2008)

Epistasis among HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility.
حسب: Lincoln, MR, وآخرون
منشور في: (2009)

Epistasis among HLA-DRB1, HLA-DQA1 and HLA-DQB1 Loci Determines Multiple Sclerosis Susceptibility
حسب: Lincoln, MR, وآخرون
منشور في: (2009)

Parental non-inherited HLA resistance alleles do not confer protection against multiple sclerosis.
حسب: Ramagopalan, S, وآخرون
منشور في: (2008)

Re: HLA-DRB1 and multiple sclerosis in Malta.
حسب: Ramagopalan, S, وآخرون
منشور في: (2008)

An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus.
حسب: DeLuca, G, وآخرون
منشور في: (2007)

No evidence for an effect of DNA methylation on multiple sclerosis severity at HLA-DRB1*15 or HLA-DRB5.
حسب: Handel, A, وآخرون
منشور في: (2010)

Multiple sclerosis, vitamin D, and HLA-DRB1*15.
حسب: Handunnetthi, L, وآخرون
منشور في: (2010)

The inheritance of resistance alleles in multiple sclerosis.
حسب: Ramagopalan, S, وآخرون
منشور في: (2007)

HLA-DRB1*15, low infant sibling exposure, and multiple sclerosis gene-environment interaction.
حسب: Ramagopalan, S, وآخرون
منشور في: (2010)

MHC transmission: insights into gender bias in MS susceptibility.
حسب: Chao, M, وآخرون
منشور في: (2011)

Maternal - offspring HLA-DRB1 compatibility in multiple sclerosis.
حسب: Willer, C, وآخرون
منشور في: (2005)

Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis.
حسب: Ramagopalan, S, وآخرون
منشور في: (2010)

HLA-DRB1 and Month-of-Birth in Multiple Sclerosis
حسب: Ebers, G, وآخرون
منشور في: (2009)

Risk alleles for multiple sclerosis in multiplex families.
حسب: D'Netto, M, وآخرون
منشور في: (2009)

Methylation of class II transactivator gene promoter IV is not associated with susceptibility to Multiple Sclerosis
حسب: Ramagopalan, S, وآخرون
منشور في: (2008)

HLA-DRB1 and month of birth in multiple sclerosis.
حسب: Ramagopalan, S, وآخرون
منشور في: (2009)

Comment: HLA-DRB1*1501 associations with magnetic resonance imaging measures of grey matter pathology in multiple sclerosis
حسب: Yates, R, وآخرون
منشور في: (2016)

An extension to a statistical approach for family based association studies provides insights into genetic risk factors for multiple sclerosis in the HLA-DRB1gene
حسب: Ramagopalan, S, وآخرون
منشور في: (2009)

Transmission of class I/II multi-locus MHC haplotypes and multiple sclerosis susceptibility: accounting for linkage disequilibrium.
حسب: Chao, M, وآخرون
منشور في: (2007)

The influence of HLA-DRB1 alleles on the susceptibility and resistance to multiple sclerosis with respect to the criteria of neuromyelitis optica
حسب: Isobe, N, وآخرون
منشور في: (2010)

The HLA class II Allele DRB1*1501 is over-represented in patients with idiopathic pulmonary fibrosis.
حسب: Jianmin Xue, وآخرون
منشور في: (2011-02-01)

Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance.
حسب: Dyment, D, وآخرون
منشور في: (2005)

A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis.
حسب: Lincoln, MR, وآخرون
منشور في: (2005)

The inheritance of resistance alleles in multiple sclerosis.
حسب: Sreeram V Ramagopalan, وآخرون
منشور في: (2007-09-01)

Structural Predictions of TCR/peptide/HLA DRB1*1501 binding
حسب: Chan, H, وآخرون
منشور في: (2008)

Vitamin-D Receptor and 1-alpha-hydroxylase Genes in Risk and Outcome of Multiple Sclerosis in Canadians
حسب: Orton, S, وآخرون
منشور في: (2010)

Multiple sclerosis susceptibility and the X chromosome.
حسب: Herrera, B, وآخرون
منشور في: (2007)

Epistatic interactions at HLA-DRB1 in Japanese patients with multiple sclerosis
حسب: Isobe, N, وآخرون
منشور في: (2009)

Parent-of-origin effects at the major histocompatibility complex in multiple sclerosis.
حسب: Chao, M, وآخرون
منشور في: (2010)

Multiple sclerosis risk variant HLA-DRB1*1501 associates with high expression of DRB1 gene in different human populations.
حسب: Antonio Alcina, وآخرون
منشور في: (2012-01-01)

Forty multiplex families with MS: Linkage analysis of chromosome 6 and HLA-DRB1
حسب: Willer, C, وآخرون
منشور في: (2002)

Influence of HLA-DRB1 alleles on the susceptibility and resistance to multiple sclerosis in Japanese patients with respect to anti-aquaporin 4 antibody status.
حسب: Isobe, N, وآخرون
منشور في: (2010)

Vitamin D-dependent rickets, HLA-DRB1, and the risk of multiple sclerosis.
حسب: Ramagopalan, S, وآخرون
منشور في: (2010)

Analysis of 45 candidate genes for disease modifying activity in multiple sclerosis.
حسب: Ramagopalan, S, وآخرون
منشور في: (2008)